AIM ImmunoTech Inc. (AMEX:AIM) Q4 2023 Earnings Call Transcript
Operator: Hello. And welcome to the AIM ImmunoTech Fiscal Year 2023 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
Stay updated with breaking news from Tom Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello. And welcome to the AIM ImmunoTech Fiscal Year 2023 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
OCALA - AIM ImmunoTech Inc. today announced that enrollment is open at Erasmus Medical Center in a Phase 1b/2 clinical trial combining AIM's Ampligen with AstraZeneca's anti-PD-L1 immune...
First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and what this means here: video OCALA, Fla.,...
/PRNewswire/ -- Ted D. Kellner, Todd Deutsch and Robert L. Chioini (collectively, the "Kellner Group") today issue the following statement in connection with...
Sam Coventry is learning what it means to be a veteran in a way no book could ever tell. Sam, 17, a student at the College of Central Florida, is part of a local effort to record veteran’s stories for the Library of Congress in Washington, D.C. The Veterans History Project (VHP) compiles video or written narratives with photographs, drawings